Skip to main content
. 2018 Jun 28;16(3):1859–1865. doi: 10.3892/etm.2018.6367

Figure 2.

Figure 2.

Pooled results of the meta-analysis of the efficacy of febuxostat in treating hyperuricemia compared with allopurinol in patients with chronic kidney disease and in renal transplant recipients after (A) 1, (B) 3, (C) 6 and (D) 12 months of administration. Comparisons were made with patients that received allopurinol. CI, confidence interval; SMD, standard mean difference.